View Single Post
Old 07-03-2008, 05:17 AM   #6
Ursula
Member
 
Ursula's Avatar
 
Join Date: Apr 2008
Location: Finland
Posts: 19
A Finnish point of view

Mts wrote:

"For the 9 week trial in Finland... Well, the Finnish gov't was only able to afford enough Herceptin for 9 weeks... and so it went. "

This is more or less rubbish. Naturally 9 weeks treatment is less expensive than one year, but the main fact is that we are looking for the optimal treatment of bc. New trial is going on, please visit:

http://www.druglib.com/trial/97/NCT00593697.html


Besides, the normal duration of taxane treatment is nine weeks in Finland. The point of FinHer study was, should we start Herceptin with Docetaxel or Vinorelbine. The decision to continue with Herceptin is always available. The vast majority of finnish HER2 patients are comfortable and safe with 9 weeks of Herceptin.
__________________
Kind Regards,

Ursula

Diagnosed 05/07 at age 42
Ductal Invasive Carsinoma Gr III, Stage IIIB:
Primary tumor 35 mm, secondary 21 mm
Node positive 13/23
Er/Pr negative (15 % /15 %)
Her 2+++
Ki-67 80 %
Mastectomy and node evacuation (rt) 05/07
3 x Taxotere + Herceptin (9 weeks)
3 x CEF
6 x Neulasta during chemos
23 x rads
Celebra for joint and PMS pain
NED
Ursula is offline   Reply With Quote